Goto Masanori, Shinmura Kazuya, Matsushima Yoshitaka, Ishino Kousuke, Yamada Hidetaka, Totsuka Yukari, Matsuda Tomonari, Nakagama Hitoshi, Sugimura Haruhiko
Division of Cancer Development System, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; Department of Tumor Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi Ward, Hamamatsu, Shizuoka 431-3192, Japan.
Department of Tumor Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi Ward, Hamamatsu, Shizuoka 431-3192, Japan.
Free Radic Biol Med. 2014 Nov;76:136-46. doi: 10.1016/j.freeradbiomed.2014.07.044. Epub 2014 Aug 20.
Lipid peroxidation directly reacts with DNA and produces various exocyclic etheno-base DNA adducts, some of which are considered to contribute to carcinogenesis. However, the system for repairing them in humans is largely unknown. We hypothesized that etheno-DNA adducts are repaired by base excision repair initiated by DNA glycosylase. To test this hypothesis, we examined the activities of the DNA glycosylase proteins OGG1, SMUG1, TDG, NEIL1, MUTYH, NTH1, MPG, and UNG2 against double-stranded oligonucleotides containing 1,N(6)-ethenoadenine (εA), 3,N(4)-ethenocytosine (εC), butanone-ethenocytosine (BεC), butanone-ethenoguanine (BεG), heptanone-ethenocytosine (HεC), or heptanone-ethenoguanine (HεG) using a DNA cleavage assay. We found that TDG is capable of removing thymine that has mispaired with εC, BεC, BεG, HεC, or HεG in vitro. We next examined the effect of TDG against etheno-DNA adducts in human cells. TDG-knockdown cells exhibited the following characteristics: (a) higher resistance to cell death caused by the induction of etheno-DNA adducts; (b) lower repair activity for εC; and (c) a modest acceleration of mutations caused by εC, compared with the rate in control cells. All these characteristics suggest that TDG exerts a repair activity against etheno-DNA adducts in human cells. These results suggest that TDG has novel repair activities toward etheno-DNA adducts.
脂质过氧化直接与DNA发生反应,产生各种环外乙烯基碱基DNA加合物,其中一些被认为与致癌作用有关。然而,人类修复这些加合物的系统在很大程度上尚不清楚。我们推测乙烯基-DNA加合物是由DNA糖基化酶启动的碱基切除修复来修复的。为了验证这一假设,我们使用DNA切割试验检测了DNA糖基化酶蛋白OGG1、SMUG1、TDG、NEIL1、MUTYH、NTH1、MPG和UNG2对含有1,N(6)-乙烯基腺嘌呤(εA)、3,N(4)-乙烯基胞嘧啶(εC)、丁酮-乙烯基胞嘧啶(BεC)、丁酮-乙烯基鸟嘌呤(BεG)、庚酮-乙烯基胞嘧啶(HεC)或庚酮-乙烯基鸟嘌呤(HεG)的双链寡核苷酸的活性。我们发现TDG能够在体外去除与εC、BεC、BεG、HεC或HεG错配的胸腺嘧啶。接下来,我们检测了TDG对人细胞中乙烯基-DNA加合物的作用。与对照细胞相比,TDG敲低细胞表现出以下特征:(a)对乙烯基-DNA加合物诱导引起的细胞死亡具有更高的抗性;(b)对εC的修复活性较低;(c)由εC引起的突变率略有加速。所有这些特征表明TDG在人细胞中对乙烯基-DNA加合物发挥修复活性。这些结果表明TDG对乙烯基-DNA加合物具有新的修复活性。